HilleVax Inc (HLVX): Rasio utang marang kapitalisasi buku

HilleVax, Inc. (HLVX) leverages its scientific authority in developing norovirus treatments by outsourcing testing to external laboratories while maintaining full patent ownership. Dependence on the cost of capital impacts R&D pace, as evidenced by the total debt-to-book capitalization ratio on the GURU.Markets system dynamic chart, where the value of 0.15 expresses the company's financial stability metric level.

HLVX HilleVax Inc.: Utang marang nilai buku ing interval 21.06.2023 - 27.09.2025

Rincian metrik komprehensif lan analitis HilleVax Inc (HLVX)

- rega saiki lan proyeksi nilai saham:

Rega saham HilleVax, Inc.|HLVX - Prakiraan konsensus analis

- data kapitalisasi bursa:

Nilai pasar HilleVax Inc.|HLVX - Nilai Dipunlarasaken Utang lan Kas

- indikator nilai buku ekuitas:

Aset Bersih saben Siji Saham HilleVax|HLVX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku hillevax.com|HLVX - Total Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas HilleVax, Inc.|HLVX - Koefisien utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas HilleVax Corp|HLVX - Utang perusahaan|Utang-utang marang kapitalisasi buku HilleVax Inc.|HLVX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan HilleVax

Ringkesan analitik perusahaan:HilleVax, Inc. HLVX

Investors utilize leverage multiples to verify an issuer's financial stability. This debt-to-equity ratio measures the proportion of borrowed capital relative to equity. A decrease in this metric minimizes liquidity risks during periods of rising interest rates. For HilleVax, Inc. (HLVX), a low debt load confirms a strong cash reserve, ensuring the autonomous funding of vaccine clinical trials without external dependence.

Analisis perusahaan pesaing